← Leaderboards
Peter M Glazer
Yale University
$37,467,142
Attributed
$48,524,495
Total exposure
25
Grants
17
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.5M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$57,008,664 · 26
By mechanism
R01$26,073,890 · 11
P01$10,266,925 · 4
R35$7,640,914 · 1
T32$4,724,326 · 2
UG3$2,442,130 · 1
UH3$2,399,844 · 1
Top collaborators
- W Mark Saltzman22 shared
- David F Stern11 shared
- Zhong Yun5 shared
- Marie E Egan4 shared
- Patrick G Gallagher4 shared
- Priti Kumar4 shared
- Danith H Ly4 shared
- Franziska Bleichert2 shared
Others in their field
Top investigators on “Dna Repair”
- John A Tainer · Scripps Research Institute$45,990,082
- Aziz Sancar · University Of North Carolina Chapel Hill$30,640,499
- Patrick Sung · University Of Texas Hlth Sci Ctr San Ant$30,442,761
- John M Essigmann · Massachusetts Institute Of Technology$27,654,594
- Loic Le Marchand · University Of Hawaii At Manoa$26,643,180
- Maria Jasin · Sloan-Kettering Institute For Cancer Res$25,953,946
Research focus
Dna RepairBaseCellsPathway InteractionsMalignant NeoplasmsDna DamageIn VivoResponseTumorDesignMutationCancer TherapyMediatingGenesGrantCancer CellCancer BiologyRepairedHypoxiaGeneticSiteOligonucleotidesGenomicsPublishing
Grant awards (144)
Targeting DNA Repair for Cancer Therapy.$1,005,000
R35 · FY2025 · CA · contact PI
Oncometabolites, DNA Repair, and Cancer$376,875
R01 · FY2025 · ES · contact PI
Yale Cancer Biology Training Grant$318,478
T32 · FY2025 · CA
Yale Cancer Biology Training Grant$500,484
T32 · FY2024 · CA
Oncometabolites, DNA Repair, and Cancer$376,875
R01 · FY2024 · ES · contact PI
Structure-Function Studies of a Cell Penetrating Antibody that Inhibits DNA Repair$223,174
R21 · FY2024 · CA · contact PI
Novel DNA Repair Inhibitors for Cancer Therapy$982,379
R35 · FY2023 · CA · contact PI
Yale Cancer Biology Training Grant$455,914
T32 · FY2023 · CA
Oncometabolites, DNA Repair, and Cancer$376,875
R01 · FY2023 · ES · contact PI
Structure-Function Studies of a Cell Penetrating Antibody that Inhibits DNA Repair$195,766
R21 · FY2023 · CA · contact PI
Poly(amine-co-ester)s for Targeted Delivery In Vivo of Gene Editing Agents to Bone Marrow and Lung$1,144,805
UH3 · FY2022 · HL
Novel DNA Repair Inhibitors for Cancer Therapy$984,900
R35 · FY2022 · CA · contact PI
Nonenzymatic Gene Editing in Treatment of Heredity Spherocytosis$620,196
R01 · FY2022 · HL
Poly(amine-co-ester)s for targeted delivery of gene editing agents to treat cystic fibrosis in animal models: SCGE Disease Models Studies Supplement$498,197
UH3 · FY2022 · HL
Yale Cancer Biology Training Grant$405,881
T32 · FY2022 · CA
PNA Nanoparticles for Gene Editing In Vivo$404,236
U01 · FY2022 · AI · contact PI
Oncometabolites, DNA Repair, and Cancer$376,875
R01 · FY2022 · ES · contact PI
Radiobiology and Radiotherapy Research Program$43,692
P30 · FY2022 · CA · contact PI
Novel DNA Repair Inhibitors for Cancer Therapy$1,004,920
R35 · FY2021 · CA · contact PI
Poly(amine-co-ester)s for Targeted Delivery In Vivo of Gene Editing Agents to Bone Marrow and Lung$756,842
UH3 · FY2021 · HL
Nonenzymatic Gene Editing in Treatment of Heredity Spherocytosis$620,196
R01 · FY2021 · HL
Yale Cancer Biology Training Grant$441,380
T32 · FY2021 · CA
PNA Nanoparticles for Gene Editing In Vivo$404,237
U01 · FY2021 · AI · contact PI
Radiobiology and Radiotherapy Research Program$43,692
P30 · FY2021 · CA · contact PI
Novel DNA Repair Inhibitors for Cancer Therapy$1,004,921
R35 · FY2020 · CA · contact PI
Poly(amine-co-ester)s for Targeted Delivery In Vivo of Gene Editing Agents to Bone Marrow and Lung$806,004
UG3 · FY2020 · HL
Nonenzymatic Gene Editing in Treatment of Heredity Spherocytosis$598,421
R01 · FY2020 · HL
PNA Nanoparticles for Gene Editing In Vivo$404,237
U01 · FY2020 · AI · contact PI
Yale Cancer Biology Training Grant$255,437
T32 · FY2020 · CA · contact PI
Radiobiology and Radiotherapy Research Program$43,692
P30 · FY2020 · CA · contact PI
Novel DNA Repair Inhibitors for Cancer Therapy$880,502
R35 · FY2019 · CA · contact PI
Poly(amine-co-ester)s for Targeted Delivery In Vivo of Gene Editing Agents to Bone Marrow and Lung$818,063
UG3 · FY2019 · HL
Nonenzymatic Gene Editing in Treatment of Heredity Spherocytosis$598,421
R01 · FY2019 · HL
PNA Nanoparticles for Gene Editing In Vivo$421,111
U01 · FY2019 · AI · contact PI
Hypoxia, DNA repair, and gene silencing$374,625
R01 · FY2019 · ES · contact PI
Yale Cancer Biology Training Grant$243,075
T32 · FY2019 · CA · contact PI
Radiobiology and Radiotherapy Research Program$43,692
P30 · FY2019 · CA · contact PI
Radiobiology and Radiotherapy Research Program$11,904
P30 · FY2019 · CA · contact PI
Novel DNA Repair Inhibitors for Cancer Therapy$1,005,000
R35 · FY2018 · CA · contact PI
Poly(amine-co-ester)s for Targeted Delivery In Vivo of Gene Editing Agents to Bone Marrow and Lung$818,063
UG3 · FY2018 · HL
Targeted correction of the human CFTR gene$554,851
R01 · FY2018 · HL
Hypoxia, DNA repair, and gene silencing$374,625
R01 · FY2018 · ES · contact PI
Yale Cancer Biology Training Grant$229,769
T32 · FY2018 · CA · contact PI
Radiobiology and Radiotherapy Research Program$43,692
P30 · FY2018 · CA · contact PI
Radiobiology and Radiotherapy Research Program$11,904
P30 · FY2018 · CA · contact PI
Radiobiology and Radiotherapy Research Program$11,904
P30 · FY2018 · CA · contact PI
Radiobiology and Radiotherapy Research Program$2,857
P30 · FY2018 · CA · contact PI
Radiobiology and Radiotherapy Research Program$2,682
P30 · FY2018 · CA · contact PI
Novel DNA Repair Inhibitors for Cancer Therapy$773,292
R35 · FY2017 · CA · contact PI
In vivo genomic editing of hematopoietic cells for HIV resistance$607,873
R01 · FY2017 · AI
Targeted correction of the human CFTR gene$554,851
R01 · FY2017 · HL
Hypoxia, DNA repair, and gene silencing$374,625
R01 · FY2017 · ES · contact PI
Cell-Penetrating Anti-DNA Antibody for Radiosensitization and Cancer Therapy$345,488
R01 · FY2017 · CA · contact PI
Yale Cancer Biology Training Grant$235,285
T32 · FY2017 · CA · contact PI
Yale Cancer Biology Training Grant$3,069
T32 · FY2017 · CA · contact PI
In vivo genomic editing of hematopoietic cells for HIV resistance$607,873
R01 · FY2016 · AI
Targeted correction of the human CFTR gene$554,851
R01 · FY2016 · HL
Bifunctional Antibodies for Melanoma Therapy$442,736
R01 · FY2016 · CA · contact PI
Hypoxia, DNA repair, and gene silencing$374,625
R01 · FY2016 · ES · contact PI
Cell-Penetrating Anti-DNA Antibody for Radiosensitization and Cancer Therapy$345,488
R01 · FY2016 · CA · contact PI
Yale Cancer Biology Training Grant$231,708
T32 · FY2016 · CA · contact PI
In vivo genomic editing of hematopoietic cells for HIV resistance$607,873
R01 · FY2015 · AI
Targeted correction of the human CFTR gene$554,851
R01 · FY2015 · HL
Bifunctional Antibodies for Melanoma Therapy$442,736
R01 · FY2015 · CA · contact PI
Hypoxia, DNA repair, and gene silencing$374,625
R01 · FY2015 · ES · contact PI
Cell-Penetrating Anti-DNA Antibody for Radiosensitization and Cancer Therapy$345,488
R01 · FY2015 · CA · contact PI
Yale Cancer Center NCTN$551,500
U10 · FY2014 · CA
Bifunctional Antibodies for Melanoma Therapy$459,361
R01 · FY2014 · CA · contact PI
Cell-Penetrating Anti-DNA Antibody for Radiosensitization and Cancer Therapy$335,123
R01 · FY2014 · CA · contact PI
Epigenetic Regulation in Hypoxic Cancer Cells$323,117
R01 · FY2014 · CA · contact PI
In vivo genomic editing of hematopoietic cells for HIV resistance$250,000
R01 · FY2014 · AI
Cell-Penetrating Anti-DNA Antibody for Radiosensitization and Cancer Therapy$345,229
R01 · FY2013 · CA · contact PI
Epigenetic Regulation in Hypoxic Cancer Cells$313,124
R01 · FY2013 · CA · contact PI
Novel triplex-engineered, BRCA1-mutated cell lines for research$244,326
R21 · FY2013 · ES · contact PI
Hypoxia, Genetic Instability and DNA Mismatch Repair$364,566
R01 · FY2012 · ES · contact PI
Epigenetic Regulation in Hypoxic Cancer Cells$333,110
R01 · FY2012 · CA · contact PI
Novel triplex-engineered, BRCA1-mutated cell lines for research$207,136
R21 · FY2012 · ES · contact PI
DNA Repair in Cancer Biology and Therapy$41,510
P01 · FY2012 · CA · contact PI
HOMOLOGY- DEPENDENT DNA REPAIR, HYPOXIA, AND CANCER THERAPY$6,919
P01 · FY2012 · CA · contact PI
DNA Repair in Cancer Biology and Therapy$1,604,667
P01 · FY2011 · CA · contact PI
Hypoxia, Genetic Instability and DNA Mismatch Repair$364,578
R01 · FY2011 · ES · contact PI
Epigenetic Regulation in Hypoxic Cancer Cells$333,110
R01 · FY2011 · CA · contact PI
HOMOLOGY- DEPENDENT DNA REPAIR, HYPOXIA, AND CANCER THERAPY$310,277
P01 · FY2011 · CA · contact PI
Research Programs-Radiobiology and Radiotherapy$29,701
P30 · FY2011 · CA · contact PI
DNA Repair in Cancer Biology and Therapy$1,684,985
P01 · FY2010 · CA · contact PI
Targeted Correction of the Human Beta-globin Gene$412,664
R01 · FY2010 · HL · contact PI
Hypoxia, Genetic Instability and DNA Mismatch Repair$368,271
R01 · FY2010 · ES · contact PI
Epigenetic Regulation in Hypoxic Cancer Cells$343,413
R01 · FY2010 · CA · contact PI
HOMOLOGY- DEPENDENT DNA REPAIR, HYPOXIA, AND CANCER THERAPY$321,820
P01 · FY2010 · CA · contact PI
Research Programs-Radiobiology and Radiotherapy$33,424
P30 · FY2010 · CA · contact PI
DNA Repair in Cancer Biology and Therapy$1,643,242
P01 · FY2009 · CA · contact PI
Targeted Correction of the Human Beta-globin Gene$402,827
R01 · FY2009 · HL · contact PI
Hypoxia, Genetic Instability and DNA Mismatch Repair$372,002
R01 · FY2009 · ES · contact PI
DNA Repair in Cancer Biology and Therapy$331,000
P01 · FY2009 · CA · contact PI
HOMOLOGY- DEPENDENT DNA REPAIR, HYPOXIA, AND CANCER THERAPY$315,197
P01 · FY2009 · CA · contact PI
Cisplatin Damage Response and Cell-to-cell Communication$275,266
R01 · FY2009 · CA · contact PI
Research Training: Radiation Therapy, Biology, Physics$174,169
T32 · FY2009 · CA · contact PI
Research Programs-Radiobiology and Radiotherapy$30,252
P30 · FY2009 · CA · contact PI
DNA Repair in Cancer Biology and Therapy$1,605,352
P01 · FY2008 · CA · contact PI
Targeted Correction of the Human Beta-globin Gene$413,345
R01 · FY2008 · HL · contact PI
Hypoxia, Genetic Instability and DNA Mismatch Repair$367,027
R01 · FY2008 · ES · contact PI
HOMOLOGY- DEPENDENT DNA REPAIR, HYPOXIA, AND CANCER THERAPY$302,309
P01 · FY2008 · CA · contact PI
Targeted mutagenesis of DNA via triple helix formation$279,050
R01 · FY2008 · CA · contact PI
Cisplatin Damage Response and Cell-to-cell Communication$275,266
R01 · FY2008 · CA · contact PI
Research Training: Radiation Therapy, Biology, Physics$199,574
T32 · FY2008 · CA · contact PI
Research Programs-Radiobiology and Radiotherapy$30,253
P30 · FY2008 · CA · contact PI
DNA Repair in Cancer Biology and Therapy$1,573,413
P01 · FY2007 · CA · contact PI
Targeted Correction of the Human Beta-globin Gene$412,318
R01 · FY2007 · HL · contact PI
Hypoxia, Genetic Instability and DNA Mismatch Repair$310,055
R01 · FY2007 · ES · contact PI
HOMOLOGY- DEPENDENT DNA REPAIR, HYPOXIA, AND CANCER THERAPY$284,260
P01 · FY2007 · CA · contact PI
Targeted mutagenesis of DNA via triple helix formation$279,050
R01 · FY2007 · CA · contact PI
Cisplatin Damage Response and Cell-to-cell Communication$270,535
R01 · FY2007 · CA · contact PI
Research Training: Radiation Therapy, Biology, Physics$232,732
T32 · FY2007 · CA · contact PI
ADMINISTRATIVE$82,235
P01 · FY2007 · CA · contact PI
Research Programs-Radiobiology and Radiotherapy$21,571
P30 · FY2007 · CA · contact PI
Hypoxia, Genetic Instability and DNA Mismatch Repair$319,316
R01 · FY2006 · ES · contact PI
Targeted mutagenesis of DNA via triple helix formation$287,384
R01 · FY2006 · CA · contact PI
Cisplatin Damage Response and Cell-to-cell Communication$283,514
R01 · FY2006 · CA · contact PI
Research Training: Radiation Therapy, Biology, Physics$229,688
T32 · FY2006 · CA · contact PI
Targeted mutagenesis of DNA via triple helix formation$95,929
R01 · FY2006 · CA · contact PI
Hypoxia, Genetic Instability and DNA Mismatch Repair$327,000
R01 · FY2005 · ES
Targeted mutagenesis of DNA via triple helix formation$294,300
R01 · FY2005 · CA
Cisplatin Damage Response and Cell-to-cell Communication$290,345
R01 · FY2005 · CA
Research Training: Radiation Therapy, Biology, Physics$186,091
T32 · FY2005 · CA
Hypoxia, Genetic Instability and DNA Mismatch Repair$327,000
R01 · FY2004 · ES
Targeted mutagenesis of DNA via triple helix formation$294,300
R01 · FY2004 · CA
RECOMBINATION INDUCED BY TRIPLE HELIX FORMATION$269,173
R01 · FY2004 · GM
Hypoxia, Genetic Instability and DNA Mismatch Repair$321,862
R01 · FY2003 · ES
TARGETED MUTAGENESIS OF DNA VIA TRIPLE HELIX FORMATION$278,184
R01 · FY2003 · CA
RECOMBINATION INDUCED BY TRIPLE HELIX FORMATION$268,938
R01 · FY2003 · GM
RECOMBINATION INDUCED BY TRIPLE HELIX FORMATION$292,364
R01 · FY2002 · GM
MUTAGENESIS IN DNA MISMATCH REPAIR DEFICIENT MICE$275,828
R01 · FY2002 · ES
TARGETED MUTAGENESIS OF DNA VIA TRIPLE HELIX FORMATION$271,853
R01 · FY2002 · CA
GENETIC INSTABILITY INDUCED BY VIRAL PROTEINS$0
P01 · FY2002 · CA
RECOMBINATION INDUCED BY TRIPLE HELIX FORMATION$304,623
R01 · FY2001 · GM
MUTAGENESIS IN DNA MISMATCH REPAIR DEFICIENT MICE$267,796
R01 · FY2001 · ES
TARGETED MUTAGENESIS OF DNA VIA TRIPLE HELIX FORMATION$265,705
R01 · FY2001 · CA
RESEARCH TRAINING: RADIATION THERAPY, BIOLOGY, PHYSICS$197,913
T32 · FY2001 · CA
GENETIC INSTABILITY INDUCED BY VIRAL PROTEINS$0
P01 · FY2001 · CA
TARGETED MUTAGENESIS OF DNA VIA TRIPLE HELIX FORMATION$266,288
R01 · FY2000 · CA
MUTAGENESIS IN DNA MISMATCH REPAIR DEFICIENT MICE$259,992
R01 · FY2000 · ES
RECOMBINATION INDUCED BY TRIPLEX TARGETED DNA DAMAGE$226,971
R01 · FY2000 · GM
RESEARCH TRAINING: RADIATION THERAPY, BIOLOGY, PHYSICS$183,679
T32 · FY2000 · CA
GENETIC INSTABILITY INDUCED BY VIRAL PROTEINS$159,739
P01 · FY2000 · CA